AR046107A1 - Uso de extractos de levadura para restaurar la integridad del intestino - Google Patents

Uso de extractos de levadura para restaurar la integridad del intestino

Info

Publication number
AR046107A1
AR046107A1 ARP040103710A ARP040103710A AR046107A1 AR 046107 A1 AR046107 A1 AR 046107A1 AR P040103710 A ARP040103710 A AR P040103710A AR P040103710 A ARP040103710 A AR P040103710A AR 046107 A1 AR046107 A1 AR 046107A1
Authority
AR
Argentina
Prior art keywords
integrity
intestine
restore
yeast extracts
effects
Prior art date
Application number
ARP040103710A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR046107A1 publication Critical patent/AR046107A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Uso de una composición oral que comprende extracto de levadura, para la fabricación de una composición oral útil para tratar los efectos producidos por enterotoxinas como consecuencia de la infección causada por bacterias patógenas tales como Clostridium difficile. Dichos efectos pueden incluir la falla de la integridad de las células del epitelio intestinal y diarrea así como otros efectos mediados por COX-2.
ARP040103710A 2003-10-13 2004-10-13 Uso de extractos de levadura para restaurar la integridad del intestino AR046107A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03023015 2003-10-13

Publications (1)

Publication Number Publication Date
AR046107A1 true AR046107A1 (es) 2005-11-23

Family

ID=34354432

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103710A AR046107A1 (es) 2003-10-13 2004-10-13 Uso de extractos de levadura para restaurar la integridad del intestino

Country Status (10)

Country Link
US (2) US20060292171A1 (es)
EP (1) EP1689417A2 (es)
JP (1) JP2007508342A (es)
CN (1) CN1889966A (es)
AR (1) AR046107A1 (es)
BR (1) BRPI0415388A (es)
CA (1) CA2542452A1 (es)
IL (1) IL175080A0 (es)
TW (1) TW200520767A (es)
WO (1) WO2005039609A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4918361B2 (ja) 2003-10-13 2012-04-18 ネステク ソシエテ アノニム エンドトキシンの作用の緩和
EP3685681A1 (en) * 2019-01-23 2020-07-29 Lesaffre et Compagnie A yeast product, and a composition comprising it, for use as a prebiotic agent
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US177534A (en) * 1876-05-16 Improvement in meat-extracts
US4595590A (en) * 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis
ATE49884T1 (de) * 1985-03-22 1990-02-15 Biocodex Lab Verwendung von saccharomyces-hefen fuer die herstellung eines arzneimittels gegen amoebiasis.
JPS61236727A (ja) * 1985-04-12 1986-10-22 Advance Res & Dev Co Ltd 抗う蝕乃至抗菌周症剤
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
FR2711528B1 (fr) * 1993-10-25 1996-02-09 Biocodex Lab Utilisation de levures Saccharomyces pour la fabrication d'un médicament contre la cryptosporidiose.
US5550106A (en) * 1994-03-04 1996-08-27 Bristol-Myers Squibb Company Low buffer nutritional composition
JP2001008636A (ja) * 1999-06-30 2001-01-16 Tanabe Seiyaku Co Ltd 感染症防止用飼料組成物
JP2001055338A (ja) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd 酵母細胞壁画分からなる薬理用組成物
JP3307627B2 (ja) * 2000-02-09 2002-07-24 オク タイン 酵母ジゴサッカロマイシスロキシイ（Ｚｙｇｏｓａｃｃｈａｒｏｍｙｃｅｓｒｏｕｘｉｉ）からサイトカラシン（Ｃｙｔｏｃｈａｌａｓｉｎ）様物質群を製造する方法。
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP2002080351A (ja) * 2000-09-07 2002-03-19 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤
FI114895B (fi) * 2001-05-14 2005-01-31 Suomen Rehu Oy Ravinnon lisäaine
PT1565547E (pt) * 2002-06-28 2008-11-03 Puleva Biotech Sa Estirpes probióticas, processo para a sua selecção, suas composições e sua utilização
JP4918361B2 (ja) * 2003-10-13 2012-04-18 ネステク ソシエテ アノニム エンドトキシンの作用の緩和

Also Published As

Publication number Publication date
CN1889966A (zh) 2007-01-03
US20100028316A1 (en) 2010-02-04
JP2007508342A (ja) 2007-04-05
CA2542452A1 (en) 2005-05-06
BRPI0415388A (pt) 2006-12-12
WO2005039609A2 (en) 2005-05-06
IL175080A0 (en) 2008-04-13
US20060292171A1 (en) 2006-12-28
EP1689417A2 (en) 2006-08-16
WO2005039609A3 (en) 2005-08-11
TW200520767A (en) 2005-07-01

Similar Documents

Publication Publication Date Title
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
BR112022015945A2 (pt) Microrganismo que compreende lyse variante e método de produção de l-aminoácido que usa o mesmo
BRPI0608796B8 (pt) método para a preparação de um extrato de planta compreendendo bacuquiol
BR112017011067A2 (pt) cepas e métodos para a partição de energia em ruminantes
CL2016000546A1 (es) Gen rf4 restaurador para la esterilidad masculina citoplasmática (cms) de tipo c del maiz, marcadores moleculares y su uso.
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
BRPI0805072B8 (pt) Composições organizadas compreendendo betaína
AR081423A1 (es) Composiciones detergentes con contenido de lipasa de streptomyces griseus y metodos para utilizarlas
CL2021002602A1 (es) Células microbianas, métodos para producir las mismas, y usos de las mismas (divisional de la solicitud no. 201902135)
SV2009002948A (es) Metodo para usar betahidroxi-beta-metilbutirato
CL2020003442A1 (es) Tiofenocarboxamidas sustituidas y análogos de las mismas
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
PE20210322A1 (es) Composiciones que comprenden microbiota coseleccionada y metodos para su uso
CL2011001769A1 (es) Composición para estimular una respuesta inmune contra la toxina shiga stx2 que comprende polipéptidos que comprenden al menos dos de las tres regiones que definen un epitopo conformacional exclusivo de stx2, los cuales se insertan dentro de una proteína andamio no stx2; dicho polipéptido; ácido nucleico; y método de producción de anticuerpos.
BR112021019349A2 (pt) Células-tronco preparadas altamente funcionais
AR069943A1 (es) Metodo para reducir la circunferencia abdominal mediante la administracion de una bacteria bifidobacterium
AR083799A1 (es) Microorganismos para la produccion de 1,3-propanodiol usando concentracion de glicerina alta
CL2022001700A1 (es) Preparación que comprende cepas probióticas para la degradación del gluten
NZ611531A (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
GT200800182A (es) Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios
BR112022010174A2 (pt) Composições para aperfeiçoamento do desempenho atlético e métodos de uso das mesmas
EP3111924A3 (en) Oral care compositions
AR046107A1 (es) Uso de extractos de levadura para restaurar la integridad del intestino
CL2009000791A1 (es) Compuestos derivados de labirintopeptina; procedimiento para prepararlos que comprende fermentar la cepa actinomadura namibiensis (dsm 6313); uso de los compuestos para tratar infecciones bacterianas, infecciones viricas y/o dolor; composicion farmaceutica que los comprenden; dna que codifica la preprolabirintopeptina a2.
AR047763A1 (es) Extracto de carne y peptonas, separados o en combinacion, para reestablecer la integridad del intestino

Legal Events

Date Code Title Description
FA Abandonment or withdrawal